 |
The Journal of Neuroscience, July 13, 2005, 25(28):6651-6657; doi:10.1523/JNEUROSCI.1474-05.2005
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Expression of Mutant NMDA Receptors in Dopamine D1 Receptor-Containing Cells Prevents Cocaine Sensitization and Decreases Cocaine Preference
Carrie L. Heusner1 and
Richard D. Palmiter1,2
1Department of Biochemistry and 2Howard Hughes Medical Institute, University of Washington, Seattle, Washington 98195
The interaction of dopamine and glutamate in limbic brain regions mediates behaviors associated with psychostimulants, which act in part to increase dopamine signaling at both D1 receptors (D1Rs) and D2 receptors. Many addictive behaviors are a result of learned associations, and NMDA receptor activation has been shown to be important for these behaviors. We hypothesized that if NMDA receptor activation in dopamine receptor-containing cells is required for the addictive properties of psychostimulants, then mice with reduced NMDA receptor activity in D1R-containing cells would have attenuated long-term behavioral changes to these drugs. We generated a mouse line in which D1R-containing cells express an NR1 NMDA receptor subunit containing a mutation in the pore that reduces calcium flux. Mice expressing the mutant NMDA receptors in D1R-containing cells have normal basal activity and display similar increases in locomotor activity when treated with acute amphetamine or cocaine. However, the mutant mice fail to display locomotor sensitization to repeated cocaine administration. In addition, these mice also have a decreased ability to form a conditioned place preference to cocaine. These data suggest that intact NMDA receptor signaling in D1R-containing cells is required for the manifestation of behaviors associated with repeated drug exposure.
Key words: dopamine; NMDA receptor; conditioned place preference; cocaine; sensitization; transgenic
Received April 14, 2005;
revised June 3, 2005;
accepted June 10, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
M. van den Buuse
Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
Schizophr Bull,
November 9, 2009;
(2009)
sbp132v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. McPherson, T. Mantamadiotis, S.-S. Tan, and A. J. Lawrence
Deletion of CREB1 from the Dorsal Telencephalon Reduces Motivational Properties of Cocaine
Cereb Cortex,
August 7, 2009;
(2009)
bhp159v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ohtsuka, M. F. Tansky, H. Kuang, S. Kourrich, M. J. Thomas, J. L. R. Rubenstein, M. Ekker, S. E. Leeman, and J. Z. Tsien
Functional disturbances in the striatum by region-specific ablation of NMDA receptors
PNAS,
September 2, 2008;
105(35):
12961 - 12966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Sun, M. Milovanovic, Y. Zhao, and M. E. Wolf
Acute and Chronic Dopamine Receptor Stimulation Modulates AMPA Receptor Trafficking in Nucleus Accumbens Neurons Cocultured with Prefrontal Cortex Neurons
J. Neurosci.,
April 16, 2008;
28(16):
4216 - 4230.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|